Oligomeric Mannose Information and Market Trend - Worldwide Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
"Oligomeric
Mannose Market - Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast 2015 - 2023"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Recently,
there has been rising interest in mannose-binding lectin (MBL) that
is chiefly a liver-derived collagen like serum protein. This is
partially due to its central role as a recognition molecule in the
complement system. In addition, it has also created interest because
of the potential clinical implications of genetically determined
differences in MBL oligomerization and serum level between
individuals. The discovery of MBL may be traced down back after the
Second World War, when it was discovered that factors in non-immune
bovine and murine serums could inhibit influenza virus-induced
haemagglutination that leads to influenza virus neutralization.
Repetition of these seminal findings has taken place and it is
observed that atleast one of these factors can be MBL. The clinical
interest in MBL originates from an observation made 40 years ago when
serum-dependent defect of phagocytosis on yeast particles was
described.
Get
Sample
Report
With TOC @
https://www.researchmoz.us/enquiry.php?type=S&repid=1345424
Mannan-binding
lectin is a vital component of the innate immune system. MBL consists
of an oligomeric structure which contains three most likely identical
peptide chains of 30kDa each. Even though MBL can form several
oligomeric forms, some indications presume that trimers and dimers
are not always biologically active and need a tetramer form to
activate the complement. It helps binding of sugar structure on
microorganism and on fading host cells. It is one of the four
recognized mediators. These mediators initiate the activation of the
component system through the lectin pathway.
Oligomeric mannose belongs to the class of
collectins in the C type lectin superfamily. It function is similar
to pattern recognition in the first line of defence in the pre-immune
host. It recognizes carbohydrate patterns, set up on the surface of
an enormous number of pathogenic microorganisms that include virus,
bacteria, fungi and protozoa. The lectin pathway of the complement
system is activated when the MBL binds to a micro-organism. Recent
studies have verified that MBL is capable of recognizing carbohydrate
structures from both altered self and infectious agents. This binding
specificity confers upon MBL the capability to function as a defense
factor that is dynamic not only against infectious agents but also
against cells and molecules abnormally produced in the host. The
recognition of the final targets may be of significance for the host
to become accustomed to abnormal physiological conditions.
In at least 12% of the common Caucasian
population, the circulating level of functional MBL is inadequate.
This makes MBL deficiency, the most common key immunodeficiency1. The
consequences of MBL deficiency can be quite restrained, numerous
studies have shown that MBL deficiency increases vulnerability to
communicable diseases and predisposes to superior severity when
infections arise.
Growing demand from the healthcare industry is the
major factor driving the global oligomeric mannose market. Rising
demand from the scientific research institutes and pharmaceutical
industry is also expected to boost demand for oligomeric mannose in
the market.
North America, Europe, Asia Pacific and Rest of
the World (RoW) are the key segments for global oligomeric mannose
market. Asia Pacific and North America are expected to boost market
demand for oligomeric mannose owing to growing demand from the
healthcare industry. Rest of the World and Europe are also expected
to boost demand owing to rising demand from the research institutions
in the region.
Some of the major players in the global oligomeric
mannose market include: Enzo Life Sciences Inc, BioPorto Diagnostics
A/S, Cayman Chemicals, Novoproteins, Acris Antibodies, Mountain
Health products and Life Plus among others.
This research report analyzes this market on the
basis of its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends
in the market, industry growth drivers, and restraints. It provides
market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report
also includes a review of micro and macro factors essential for the
existing market players and new entrants along with detailed value
chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Report
Enquiry and Other Query @
https://www.researchmoz.us/enquiry.php?type=E&repid=1345424
Comments
Post a Comment